Primary Cutaneous Cryptococcosis in Immunocompetent Patients: Recognition and Management

Area of Science:

• Mycology
• Dermatology
• Infectious Diseases

Background:

• Primary cutaneous cryptococcosis (PCC) is a rare fungal infection affecting the skin.
• It typically occurs in immunocompetent individuals due to direct yeast inoculation.
• PCC can mimic other dermatologic conditions, complicating diagnosis.

Purpose of the Study:

• To provide a comprehensive overview of PCC epidemiology, clinical features, diagnosis, and management.
• To highlight the importance of distinguishing PCC from disseminated cryptococcosis and similar conditions.
• To offer practical diagnostic algorithms for clinicians.

Main Methods:

• Literature review of primary cutaneous cryptococcosis.
• Analysis of epidemiological data, clinical presentations, and diagnostic approaches.
• Evaluation of current management strategies and treatment outcomes.

Main Results:

• PCC is caused by Cryptococcus species (C. neoformans, C. gattii) and often follows skin trauma.
• Clinical presentation can mimic bacterial infections, pyoderma gangrenosum, or mycobacterial infections.
• Oral azoles, particularly fluconazole, are effective treatments for immunocompetent patients.

Conclusions:

• Dermatologists play a key role in the early identification of PCC.
• Accurate diagnosis and timely management improve patient outcomes.
• PCC in immunocompetent hosts generally has a favorable prognosis with appropriate treatment.